Abstract

The high M1 sterility is the factor limiting the increase of the mutation frequency after treatment with nitrosamides like N-methyl-N′-nitro-N-nitrosoguanidine, N-methyl-N-nitrosourea, N-methyl-N-nitrosourethane and N-ethyl-N-nitrosourethane, whereas for ethylvinylnitrosamine-treatment the limiting factor is the toxic action on the M1 seed germination. The decrease of mutation frequency at high dimethylnitrosamine doses is explained by the inhibition of enzymes or enzyme-like system which hydroxylate nitrosaminesin vivo and thus enable the production of a mutagenic alkylating intermediate. The increase of mutation frequency after treatment with X-rays is limited both by the decreased M1 survival and M1 fertility.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.